First, it moderately downregulated the p110α level, leading to a slight reduction in the P-AKT level, which is in line with a previous study on nasopharyngeal carcinoma showing that Sox2 can activate AKT by inducing the transcription of the PIK3CA gene [50]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.